Next Article in Journal
Antioxidative Peptides Derived from Enzyme Hydrolysis of Bone Collagen after Microwave Assisted Acid Pre-Treatment and Nitrogen Protection
Next Article in Special Issue
Proteomic Analysis of Whole Human Saliva Detects Enhanced Expression of Interleukin-1 Receptor Antagonist, Thioredoxin and Lipocalin-1 in Cigarette Smokers Compared to Non-Smokers
Previous Article in Journal
The Bondons: The Quantum Particles of the Chemical Bond
Previous Article in Special Issue
Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening Programs
Int. J. Mol. Sci. 2010, 11(11), 4257-4266; doi:10.3390/ijms11114257

α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease

* ,
Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Tokyo, 183-8526, Japan
* Author to whom correspondence should be addressed.
Received: 14 September 2010 / Revised: 20 October 2010 / Accepted: 28 October 2010 / Published: 29 October 2010
(This article belongs to the Special Issue Biomarkers)
View Full-Text   |   Download PDF [145 KB, uploaded 19 June 2014]


Parkinson’s disease (PD) is the most common form of movement disorder and affects approximately 4% of the population aged over 80 years old. Currently, PD cannot be prevented or cured, and no single diagnostic biomarkers are available. Notably, recent studies suggest that two familial PD-linked molecules, α-synuclein and DJ-1, are present in cerebrospinal fluid (CSF) and that their levels may be altered during the progression of PD. In this regard, sensitive and accurate methods for evaluation of α-synuclein and DJ-1 levels in the CSF and blood have been developed, and the results suggest that the levels of both molecules are significantly decreased in the CSF in patients with PD compared with age-matched controls. Furthermore, specific detection and quantification of neurotoxic oligometric forms of α-synuclein in the blood using enzyme-linked immunosorbent assays might be expected as potential peripheral biomarkers for PD, although further validation is required. Currently, neither α-synuclein nor DJ-1 is satisfactory as a single biomarker for PD, but combinatory evaluation of these biological fluid molecules with other biomarkers and imaging techniques may provide reliable information for diagnosis of PD.
Keywords: Parkinson’s disease; cerebrospinal fluid; biomarker; α-synuclein; DJ-1 Parkinson’s disease; cerebrospinal fluid; biomarker; α-synuclein; DJ-1
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Waragai, M.; Sekiyama, K.; Sekigawa, A.; Takamatsu, Y.; Fujita, M.; Hashimoto, M. α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease. Int. J. Mol. Sci. 2010, 11, 4257-4266.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert